Here are four things to know:
1. The nanobiology company’s patented NanoBone Bone Graft incorporates nanocrystalline hydroxyapatite into an amorphous silica gel.
2. NanoBone’s nanocrystalline HA is similar to HA particles naturally occurring in human bone.
3. NanoBone is designed to be used as a standalone graft. It has been used in Europe for 10 years and has been implanted in nearly 400,000 cases.
4. The company recently appointed William Lapp as the U.S. director of sales on the East Coast. NanoBone products have been available in the U.S. since 2015.
More articles on biologics:
InVivo enters new partnership to study spinal scaffold & stem cell combination: 3 notes
Bioventus selects Pfizer as exclusive distribution partner for hip, knee OA solution in Brazil: 3 notes
Orthobiologics company completes 250 cases with OsteoCrete magnesium-based bone void filler: 3 notes
